• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Algorhythm Holdings Inc.

    12/10/24 4:05:24 PM ET
    $RIME
    Diversified Electronic Products
    Consumer Staples
    Get the next $RIME alert in real time by email
    SC 13G 1 g084590_sch13g.htm SC 13G

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

     

    Algorhythm Holdings, Inc.

    (Name of Issuer)

     

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)

     

    829322403

    (CUSIP Number)

     

    December 5, 2024

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    CUSIP No. 829322403   13G   Page 2 of 10 Pages
       
    1. NAMES OF REPORTING PERSONS

    Ionic Ventures, LLC
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ☒
    (b) ☐
    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California, United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    1,844,080 (1)

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    1,844,080 (1)

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,844,080 (1)

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.9% (1)

    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    OO

     

    (1) As more fully described in Item 4 of this Statement on Schedule 13G (this “Schedule 13G”), such shares and percentage are based on 18,415,176 shares of the issuer’s common stock, par value $0.01 per share (the “Common Stock”), outstanding as of November 20, 2024 after giving effect to the offering of 4,200,000 shares of Common Stock as set forth in the issuer’s Prospectus (File No. 333-283178), filed with the U.S. Securities and Exchange Commission on December 6, 2024 (the “Prospectus”) (and assuming no exercise of pre-funded common stock purchase warrants issued pursuant to the Prospectus (the “Pre-Funded Warrants”), and (i) consists of 1,800,000 shares of Common Stock directly owned by the reporting person, (ii) does not give full effect to the Pre-Funded Warrants directly owned by the reporting person, subject to a beneficial ownership blocker, and (iii) does not give effect to Series A common stock purchase warrants of the issuer (the “Series A Warrants”) directly owned by the reporting person or Series B common stock purchase warrants of the issuer (the “Series B Warrants”, and together with the Series A Warrants, the “Warrants”) directly owned by the reporting person, which are not exercisable until the shares issuable upon exercise thereof are approved by the stockholders of the issuer.

     

     

     

     

    CUSIP No. 829322403   13G   Page 3 of 10 Pages

     

    1.

    NAMES OF REPORTING PERSONS

     

    Ionic Management, LLC

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ☒
    (b) ☐
    3.

    SEC USE ONLY

     

    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware, United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER
     
    0
    6.

    SHARED VOTING POWER

     

    1,844,080 (1)

    7. SOLE DISPOSITIVE POWER
     
    0
    8.

    SHARED DISPOSITIVE POWER

     

    1,844,080 (1)

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,844,080 (1)

    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions) ☐
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.9% (1)

    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    OO

     

    (1) As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 18,415,176 shares of the issuer’s Common Stock outstanding as of November 20, 2024, after giving effect to the offering of 4,200,000 shares of Common Stock as set forth in the issuer’s Prospectus (and assuming no exercise of Pre-Funded Warrants), and (i) consist of 1,800,000 shares of Common Stock directly owned by the reporting person, (ii) does not give full effect to the Pre-Funded Warrants directly owned by the reporting person, subject to a beneficial ownership blocker, and (iii) does not give effect to Warrants directly owned by the reporting person, which are not exercisable until the shares issuable upon exercise thereof are approved by the stockholders of the issuer.

     

     

     

     

    CUSIP No. 829322403   13G   Page 4 of 10 Pages
       
    1.

    NAMES OF REPORTING PERSONS

     

    Brendan O’Neil

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ☒
    (b) ☐
    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    1,844,080 (1)

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    1,844,080 (1)

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,844,080 (1)

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.9% (1)

    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    IN

     

    (1) As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 18,415,176 shares of the issuer’s Common Stock outstanding as of November 20, 2024, after giving effect to the offering of 4,200,000 shares of Common Stock as set forth in the issuer’s Prospectus (and assuming no exercise of Pre-Funded Warrants), and (i) consist of 1,800,000 shares of Common Stock directly owned by the reporting person, (ii) does not give full effect to the Pre-Funded Warrants directly owned by the reporting person, subject to a beneficial ownership blocker, and (iii) does not give effect to Warrants directly owned by the reporting person, which are not exercisable until the shares issuable upon exercise thereof are approved by the stockholders of the issuer.

     

     

     

     

    CUSIP No. 829322403   13G   Page 5 of 10 Pages
       
    1.

    NAMES OF REPORTING PERSONS

     

    Keith Coulston

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ☒
    (b) ☐
    3.